home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Advanced Drug Delivery to the Central Nervous System in Nonhuman Primates

 
  April 01, 2025  
     
 
Xtalks, Online
2025-04-16


In this webinar, the attendees will gain insights into the latest research methodologies used to optimize central nervous system (CNS)-targeted drug delivery.

A key highlight of the webinar will be the presentation of novel data from a pilot study. This study utilized adeno-associated virus (AAV)-based gene therapy with fluorescent tagging, allowing for advanced visualization of biodistribution through histological and tomography-based imaging techniques.

During the webinar, the speakers will discuss a groundbreaking approach where a fluorescent-tagged transgene was delivered via AAV to the brain, enabling visualization using histological techniques and tomography imaging. This innovative approach allowed researchers to generate highly detailed 3D reconstructions of biodistribution patterns, layered with magnetic resonance imaging (MRI) anatomical data to create a comprehensive visualization of gene transport. This type of data is invaluable for researchers designing CNS-targeted drug delivery programs as it provides both qualitative and quantitative insights into treatment efficacy and precision.

The webinar will also address translational considerations for CNS drug delivery. The speakers’ insights will be particularly valuable for professionals looking to bridge the gap between preclinical research and clinical implementation.

Register for this webinar to gain a clear understanding of how to design more effective CNS drug delivery studies and avoid common pitfalls in the field.

Keywords: Gene Therapy, Drug Development, Brain, Drug Delivery, Clinical Research, CRO, Central Nervous System, Therapeutic Areas, CNS, AAV, Pre-Clinical, CGT
 
 
Organized by: Xtalks
Invited Speakers: Jake McDonald, PhD, ATS, CEO, Envol Biomedical
Dr. Reinier Espinosa, Lead Surgeon and Study Director, Envol Biomedical
Dr. Ernesto Salegio, PhD, Vice President, Segment Leader Translational & Pre-Clinical Research, ClearPoint Neuro
 
Deadline for Abstracts: 2025-04-16
 
Registration: Free Registration
E-mail: tristan@xtalks.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.